BLOOD CLOTTING AMONG EVRA USERS
Evra Contraceptive Patch is a convenient form of contraception. The user applies the patch once a week for 3 weeks and off 1 week. But recent study shows Evra causes more venous thromboembolism among users when compared with oral contraceptives. It is recommended that obese women not be prescribed Evra. Other risk factors include smoking, fever, sauna/hot tub, prolonged immobility (e.g. on a plane), trauma to the body.